Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 7 | 2022 | 438 | 2.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2019 | 375 | 1.590 |
Why?
|
| Health Care Costs | 6 | 2019 | 228 | 1.590 |
Why?
|
| Early Detection of Cancer | 7 | 2023 | 501 | 1.560 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 57 | 1.510 |
Why?
|
| Communication | 6 | 2021 | 194 | 1.450 |
Why?
|
| Physician-Patient Relations | 3 | 2019 | 187 | 1.420 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2020 | 382 | 1.330 |
Why?
|
| Vaccination | 6 | 2022 | 635 | 1.260 |
Why?
|
| Humans | 48 | 2023 | 17611 | 1.220 |
Why?
|
| Health Expenditures | 4 | 2020 | 75 | 1.210 |
Why?
|
| Genomics | 3 | 2021 | 55 | 1.200 |
Why?
|
| Medical Oncology | 4 | 2016 | 32 | 1.170 |
Why?
|
| Parents | 7 | 2020 | 296 | 1.080 |
Why?
|
| Mass Screening | 7 | 2023 | 661 | 1.030 |
Why?
|
| Psychometrics | 2 | 2019 | 121 | 1.020 |
Why?
|
| Melanoma | 2 | 2023 | 35 | 0.980 |
Why?
|
| Vaccines | 5 | 2022 | 212 | 0.960 |
Why?
|
| Patient Preference | 2 | 2017 | 48 | 0.900 |
Why?
|
| Professional-Family Relations | 3 | 2020 | 49 | 0.800 |
Why?
|
| Duty to Recontact | 1 | 2021 | 2 | 0.750 |
Why?
|
| Leadership | 2 | 2020 | 39 | 0.750 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 12 | 0.740 |
Why?
|
| Washington | 6 | 2021 | 374 | 0.740 |
Why?
|
| Physicians | 3 | 2020 | 137 | 0.740 |
Why?
|
| Genetic Research | 2 | 2019 | 8 | 0.740 |
Why?
|
| Behavioral Medicine | 1 | 2020 | 4 | 0.730 |
Why?
|
| Cancer Survivors | 2 | 2020 | 83 | 0.690 |
Why?
|
| Ethics Committees, Research | 1 | 2019 | 10 | 0.660 |
Why?
|
| Workflow | 1 | 2019 | 11 | 0.660 |
Why?
|
| Genetic Testing | 3 | 2022 | 70 | 0.660 |
Why?
|
| Policy | 1 | 2019 | 18 | 0.660 |
Why?
|
| Social Determinants of Health | 1 | 2019 | 37 | 0.660 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 86 | 0.650 |
Why?
|
| Health Communication | 2 | 2017 | 16 | 0.650 |
Why?
|
| Adult | 16 | 2023 | 7598 | 0.630 |
Why?
|
| Risk Assessment | 4 | 2019 | 1097 | 0.620 |
Why?
|
| Decision Making | 2 | 2011 | 183 | 0.620 |
Why?
|
| Colorectal Neoplasms | 4 | 2021 | 613 | 0.620 |
Why?
|
| Patient Selection | 4 | 2011 | 190 | 0.620 |
Why?
|
| Sunburn | 1 | 2018 | 3 | 0.610 |
Why?
|
| Health Behavior | 2 | 2018 | 359 | 0.610 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 67 | 0.600 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 172 | 0.590 |
Why?
|
| Primary Health Care | 3 | 2023 | 766 | 0.590 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 262 | 0.580 |
Why?
|
| Papillomavirus Vaccines | 2 | 2017 | 113 | 0.580 |
Why?
|
| Ambulatory Care | 1 | 2019 | 244 | 0.570 |
Why?
|
| Adolescent | 10 | 2023 | 3651 | 0.570 |
Why?
|
| Papillomavirus Infections | 2 | 2017 | 133 | 0.570 |
Why?
|
| Insurance Coverage | 2 | 2019 | 106 | 0.560 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 8 | 0.560 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 4 | 0.560 |
Why?
|
| Counseling | 1 | 2018 | 189 | 0.540 |
Why?
|
| Mothers | 1 | 2017 | 105 | 0.530 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 59 | 0.530 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 1309 | 0.530 |
Why?
|
| Disclosure | 1 | 2016 | 19 | 0.520 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 368 | 0.510 |
Why?
|
| Evidence-Based Medicine | 3 | 2016 | 185 | 0.480 |
Why?
|
| Value-Based Purchasing | 1 | 2014 | 3 | 0.480 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2014 | 20 | 0.470 |
Why?
|
| Female | 17 | 2021 | 12608 | 0.450 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 212 | 0.450 |
Why?
|
| Male | 16 | 2021 | 10008 | 0.430 |
Why?
|
| United States | 9 | 2023 | 3956 | 0.390 |
Why?
|
| Neptune | 1 | 2021 | 1 | 0.390 |
Why?
|
| Advisory Committees | 3 | 2016 | 110 | 0.380 |
Why?
|
| Quality of Life | 4 | 2022 | 507 | 0.380 |
Why?
|
| Risk Factors | 6 | 2020 | 3325 | 0.360 |
Why?
|
| Patient Education as Topic | 2 | 2009 | 211 | 0.350 |
Why?
|
| Middle Aged | 10 | 2021 | 7911 | 0.330 |
Why?
|
| Uncertainty | 1 | 2009 | 7 | 0.330 |
Why?
|
| Cost of Illness | 2 | 2020 | 92 | 0.330 |
Why?
|
| Vaccination Refusal | 2 | 2019 | 9 | 0.320 |
Why?
|
| Family | 2 | 2022 | 111 | 0.320 |
Why?
|
| Qualitative Research | 2 | 2020 | 254 | 0.320 |
Why?
|
| Physicians, Primary Care | 2 | 2021 | 72 | 0.310 |
Why?
|
| Aged | 8 | 2021 | 6095 | 0.290 |
Why?
|
| Pharmacogenetics | 1 | 2007 | 15 | 0.290 |
Why?
|
| Colonoscopy | 2 | 2021 | 251 | 0.290 |
Why?
|
| Incidental Findings | 1 | 2007 | 26 | 0.290 |
Why?
|
| Preventive Health Services | 3 | 2016 | 159 | 0.270 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 381 | 0.270 |
Why?
|
| Registries | 2 | 2014 | 471 | 0.270 |
Why?
|
| Health Policy | 1 | 2007 | 122 | 0.270 |
Why?
|
| Interviews as Topic | 3 | 2019 | 305 | 0.260 |
Why?
|
| Referral and Consultation | 1 | 2007 | 167 | 0.260 |
Why?
|
| Treatment Outcome | 4 | 2022 | 1259 | 0.260 |
Why?
|
| Physical Examination | 2 | 2023 | 20 | 0.250 |
Why?
|
| Minority Groups | 2 | 2020 | 101 | 0.240 |
Why?
|
| Exercise Therapy | 2 | 2018 | 71 | 0.230 |
Why?
|
| Young Adult | 5 | 2019 | 2427 | 0.230 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 304 | 0.230 |
Why?
|
| Pilot Projects | 2 | 2016 | 218 | 0.220 |
Why?
|
| Infant | 5 | 2020 | 1171 | 0.220 |
Why?
|
| Veterans Health | 1 | 2023 | 21 | 0.220 |
Why?
|
| Prevalence | 2 | 2015 | 884 | 0.210 |
Why?
|
| Attitude to Health | 2 | 2018 | 164 | 0.200 |
Why?
|
| Genetic Counseling | 1 | 2022 | 26 | 0.200 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 1322 | 0.200 |
Why?
|
| Burnout, Professional | 1 | 2021 | 14 | 0.190 |
Why?
|
| Smartphone | 1 | 2021 | 11 | 0.190 |
Why?
|
| Models, Economic | 1 | 2020 | 19 | 0.180 |
Why?
|
| Research Personnel | 1 | 2020 | 27 | 0.180 |
Why?
|
| Child | 5 | 2018 | 2474 | 0.180 |
Why?
|
| Medical Overuse | 1 | 2020 | 13 | 0.170 |
Why?
|
| Telephone | 1 | 2021 | 161 | 0.170 |
Why?
|
| Occult Blood | 1 | 2021 | 153 | 0.170 |
Why?
|
| Pancreas | 1 | 2019 | 14 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 26 | 0.170 |
Why?
|
| Infant, Newborn | 3 | 2019 | 844 | 0.160 |
Why?
|
| Consumer Behavior | 1 | 2019 | 29 | 0.160 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 79 | 0.160 |
Why?
|
| Postoperative Complications | 1 | 2019 | 102 | 0.160 |
Why?
|
| Self-Examination | 1 | 2018 | 4 | 0.150 |
Why?
|
| Sunscreening Agents | 1 | 2018 | 5 | 0.150 |
Why?
|
| Skin Pigmentation | 1 | 2018 | 6 | 0.150 |
Why?
|
| Braces | 1 | 2018 | 2 | 0.150 |
Why?
|
| Scoliosis | 1 | 2018 | 3 | 0.150 |
Why?
|
| Preventive Medicine | 1 | 2018 | 24 | 0.150 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 47 | 0.150 |
Why?
|
| Medical History Taking | 1 | 2017 | 35 | 0.150 |
Why?
|
| Social Work | 1 | 1997 | 12 | 0.140 |
Why?
|
| Homeless Persons | 1 | 1997 | 26 | 0.140 |
Why?
|
| Physician's Role | 1 | 2017 | 31 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 415 | 0.140 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2016 | 2 | 0.140 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 24 | 0.140 |
Why?
|
| Ethnic Groups | 1 | 2020 | 485 | 0.140 |
Why?
|
| Housing | 1 | 1997 | 39 | 0.140 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2016 | 24 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 55 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2016 | 62 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 1900 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2015 | 46 | 0.130 |
Why?
|
| Perception | 1 | 2015 | 58 | 0.120 |
Why?
|
| Family Health | 1 | 2015 | 44 | 0.120 |
Why?
|
| Northwestern United States | 1 | 2014 | 53 | 0.120 |
Why?
|
| Health Information Systems | 1 | 2014 | 3 | 0.120 |
Why?
|
| Mass Vaccination | 1 | 2014 | 22 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1210 | 0.110 |
Why?
|
| Hospitalization | 1 | 2019 | 797 | 0.110 |
Why?
|
| Data Collection | 1 | 2014 | 256 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 568 | 0.100 |
Why?
|
| Internet | 1 | 2014 | 231 | 0.100 |
Why?
|
| Manipulation, Spinal | 1 | 2011 | 3 | 0.100 |
Why?
|
| Age Factors | 3 | 2021 | 917 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 11 | 0.100 |
Why?
|
| Software | 1 | 2021 | 22 | 0.100 |
Why?
|
| Acupuncture Therapy | 1 | 2011 | 35 | 0.100 |
Why?
|
| Low Back Pain | 1 | 2011 | 54 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 318 | 0.090 |
Why?
|
| Interview, Psychological | 1 | 2011 | 19 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2011 | 127 | 0.090 |
Why?
|
| Time Factors | 2 | 2011 | 1086 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 322 | 0.080 |
Why?
|
| Focus Groups | 1 | 2009 | 147 | 0.080 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 531 | 0.080 |
Why?
|
| Patient-Centered Care | 2 | 2023 | 197 | 0.070 |
Why?
|
| Patient Participation | 1 | 2009 | 133 | 0.070 |
Why?
|
| Pharmacokinetics | 1 | 2007 | 1 | 0.070 |
Why?
|
| Biotransformation | 1 | 2007 | 3 | 0.070 |
Why?
|
| Genetic Privacy | 1 | 2007 | 2 | 0.070 |
Why?
|
| Cholesterol | 2 | 2016 | 106 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2021 | 681 | 0.070 |
Why?
|
| Genetic Services | 1 | 2005 | 2 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2007 | 141 | 0.070 |
Why?
|
| Cholesterol, LDL | 2 | 2016 | 119 | 0.070 |
Why?
|
| Biomarkers | 2 | 2016 | 301 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 454 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1115 | 0.060 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 238 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2007 | 280 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2020 | 1409 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2017 | 250 | 0.060 |
Why?
|
| Stroke | 2 | 2016 | 311 | 0.060 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2023 | 127 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2022 | 28 | 0.050 |
Why?
|
| Patients | 1 | 2022 | 34 | 0.050 |
Why?
|
| Job Satisfaction | 1 | 2021 | 20 | 0.050 |
Why?
|
| Workplace | 1 | 2021 | 30 | 0.050 |
Why?
|
| Workload | 1 | 2021 | 30 | 0.050 |
Why?
|
| Sigmoidoscopy | 1 | 2021 | 65 | 0.050 |
Why?
|
| Mobile Applications | 1 | 2021 | 17 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 205 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2020 | 55 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 46 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 516 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 89 | 0.040 |
Why?
|
| Health Personnel | 1 | 2020 | 124 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 81 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 630 | 0.040 |
Why?
|
| Linear Models | 1 | 2018 | 231 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1997 | 4 | 0.040 |
Why?
|
| Social Marketing | 1 | 2017 | 13 | 0.040 |
Why?
|
| Power (Psychology) | 1 | 2016 | 3 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2016 | 18 | 0.030 |
Why?
|
| Food Services | 1 | 1997 | 15 | 0.030 |
Why?
|
| Trust | 1 | 2017 | 29 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 264 | 0.030 |
Why?
|
| Massachusetts | 1 | 1997 | 93 | 0.030 |
Why?
|
| Ezetimibe | 1 | 2016 | 4 | 0.030 |
Why?
|
| Dermatology | 1 | 2016 | 6 | 0.030 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2016 | 7 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 19 | 0.030 |
Why?
|
| Simvastatin | 1 | 2016 | 11 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2016 | 47 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 2016 | 40 | 0.030 |
Why?
|
| Urban Population | 1 | 1997 | 116 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 246 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2447 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2016 | 51 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 710 | 0.030 |
Why?
|
| Mental Health Services | 1 | 1997 | 154 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 332 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 171 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 1267 | 0.030 |
Why?
|
| Public Health | 1 | 2014 | 80 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2014 | 86 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 309 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2011 | 27 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 2570 | 0.020 |
Why?
|
| Publishing | 1 | 2005 | 8 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 80 | 0.020 |
Why?
|
Concepts
(225)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->